Sirna Therapeutics Inc Watch

from DEFA14A 10 pages Form of Voting Agreement

from 8-K 10 pages Form of Voting Agreement

from 10-Q 2 pages Material contract

from 10-Q 6 pages Sirna Therapeutics, Inc. 2005 Performance Incentive Plan Terms and Conditions of Nonqualified Stock Option

from 10-Q 6 pages Sirna Therapeutics, Inc. 2005 Performance Incentive Plan Terms and Conditions of Incentive Stock Option

from 10-Q 20 pages Sirna Therapeutics, Inc. 2005 Performance Incentive Plan

from 10-Q 12 pages Indemnification Agreement

from 10-Q 62 pages Strategic Alliance Agreement

from 10-Q 4 pages Confidential

from 10-Q 53 pages Lease Agreement

from 10-Q 20 pages 1. Positions, Location and Scope of Employment. Upon the Effective Time, You Shall Serve as Senior Vice President and Chief Financial Officer of the Company and Will Be Based in San Francisco, California at the Company’s Corporate Headquarters. You Shall Render Such Business and Professional Services in the Performance of Your Duties, Consistent With Your Position Within the Company, Consistent With the Bylaws of the Company and the Fiduciary Duties of a Corporate Officer of the Company, and as Shall Reasonably Be Assigned to You by the Company’s President and Chief Executive Officer and/or the Board of Directors (The “Board”), and You Shall Report Directly to the President and Chief Executive Officer. You Shall Perform Your Duties Faithfully and to the Best of Your Ability and Shall Devote Your Full Business Efforts and Time to the Company. You Hereby Agree to Relocate to and Establish Your Primary Residence in San Francisco Bay Area Within Ninety (90) Days of the Effective Time. 2. Compensation

from 10-Q 12 pages Indemnification Agreement

from 10-Q 1 page Sirna Therapeutics, Inc. 2005 Amended Director Compensation Plan

from 10-Q 40 pages Strategic Alliance Agreement Between Sirna Therapeutics, Inc. and Allergan Effective September 28, 2005 Strategic Alliance Agreement 1. Definitions

from 10-Q 3 pages August 18, 2005 Stock Options

from 10-Q 8 pages 2. Compensation

from 10-K 9 pages March 30, 2005 Dr. Nassim Usman 2129 Night Sky Lane Lafayette, Co 80026 Re: Addendum to the Employment Letter Dated February 11, 2003, as Amended by Letter Dated April 14, 2003

from 10-K 48 pages China Basin Landing Office Lease

from 10-K 64 pages Sale Agreement Among Sirna Therapeutics, Inc., Skinetics Biosciences, Inc., Each of the Sellers Party Hereto and David Shaw, as Seller Agent Dated as of October 12, 2004, as Amended by Amendment No. 1, Dated as of November 19, 2004 and by Amendment No. 2, Dated as of December 6, 2004 [Conformed Copy]

from 10-K 13 pages 2. Compensation